Skip Navigation

International Journal for Quality in Health Care 2005 17(6):463-464; doi:10.1093/intqhc/mzi085
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Apolone, G.
Right arrow Articles by Mosconi, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Apolone, G.
Right arrow Articles by Mosconi, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal for Quality in Health Care vol. 17 no. 6 © The Author 2005. Published by Oxford University Press on behalf of International Society for Quality in Health Care; all rights reserved

Editorial

Satisfaction surveys: do we really need new questionnaires?

The first 10% of the full text of this article appears below.

Before introducing a new intervention in the health care setting, whether it is a technology, a new drug, or an evaluative tool, its validity must be fully tested as the final goal is to improve patients (quality of) care, as any change in patients care is potentially associated with benefits, risks, and costs.

‘Validity’ is not a yes/no attribute, but the results of the accumulation of evidence were produced through a long process where hypotheses are formulated and then sequentially challenged with several empirical testings. A good example is the process of development and validation of new drugs. The regulatory agencies that are responsible for the first evaluation of the scientific and clinical value of new . . . [Full Text of this Article]

Giovanni Apolone and Paola Mosconi

Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, Italy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?